Foundation Medicine Inc (FMI) CEO Sells $605,786.64 in Stock
Foundation Medicine Inc (NASDAQ:FMI) CEO Troy Cox sold 9,012 shares of the business’s stock in a transaction dated Thursday, February 15th. The stock was sold at an average price of $67.22, for a total transaction of $605,786.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Troy Cox also recently made the following trade(s):
- On Wednesday, February 7th, Troy Cox sold 26,713 shares of Foundation Medicine stock. The stock was sold at an average price of $70.13, for a total transaction of $1,873,382.69.
Shares of Foundation Medicine Inc (NASDAQ:FMI) opened at $75.75 on Thursday. Foundation Medicine Inc has a 52 week low of $22.40 and a 52 week high of $78.59. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.24 and a quick ratio of 2.03.
A number of equities analysts recently weighed in on the stock. BidaskClub downgraded shares of Foundation Medicine from a “buy” rating to a “hold” rating in a report on Tuesday, January 16th. Zacks Investment Research upgraded Foundation Medicine from a “hold” rating to a “buy” rating and set a $66.00 price objective on the stock in a research note on Wednesday, December 6th. Finally, Cowen assumed coverage on Foundation Medicine in a research note on Thursday, February 15th. They issued an “outperform” rating and a $90.00 price objective on the stock. Five research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $59.80.
ILLEGAL ACTIVITY WARNING: “Foundation Medicine Inc (FMI) CEO Sells $605,786.64 in Stock” was first posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this news story on another domain, it was stolen and reposted in violation of US & international trademark & copyright law. The original version of this news story can be accessed at https://theolympiareport.com/2018/02/22/foundation-medicine-inc-fmi-ceo-sells-605786-64-in-stock.html.
Foundation Medicine Company Profile
Foundation Medicine, Inc is a molecular information company. The Company sells products that are enabled by its molecular information platform to physicians and biopharmaceutical companies. It is engaged in the business of delivering molecular information about cancer to its customers. Its platform includes various methods and algorithms for analyzing specimens across various types of cancer.
Receive News & Ratings for Foundation Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Foundation Medicine and related companies with MarketBeat.com's FREE daily email newsletter.